Clinical Trial Update: 9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 extension study evaluating asenapine and olanzapine for mania in bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Saphris (asenapine)
• Zyprexa (olanzapine)

Snippet

Sponsor: Organon and Co | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED